(MedPage Today) — The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication.
Zoliflodacin is the first of a new class of antibiotics…
Source link : https://www.medpagetoday.com/infectiousdisease/stds/119026
Author :
Publish date : 2025-12-15 21:07:00
Copyright for syndicated content belongs to the linked Source.
